Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Melanophilin Mouse anti-Human, Clone: OTI6E8, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA527001

Catalog No. PIMA527001


Add to cart

Description

Description

Slac2-a (for synaptotagmin-like protein (Slp) homolog lacking C2 domains-a) links Rab27A on melanosomes with Myosin VA in melanocytes. Slac2-a binds Myosin VA through a C-terminal region and GTP-bound Rab27A through its synaptotagmin-like protein homology domain (SHD), which is located near the N-terminus. The transport of pigment and cytotoxic granules in melanocytes requires the stable formation of this complex, and thus mutations in the binding domains of the three protein components may cause albinism and/or severe immune disorders.
Specifications

Specifications

Melanophilin
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3
Q9BV36
2210418F23Rik, 5031433I09Rik, AW228792, D1Wsu84e, Slac-2a, l(1)-3Rk, l1Rk3, ln, exophilin-3, leaden protein, slaC2-a, slp homolog lacking C2 domains a, synaptotagmin-like protein 2a
Mouse
IgG2a
100 μL
-20° C, Avoid Freeze/Thaw Cycles
Primary
79083
Immunohistochemistry (Paraffin), Western Blot
OTI6E8
Unconjugated
MLPH
Liquid
MLPH
Human recombit protein fragment corresponding to amino acids 295-600 of MLPH produced in E.coli
Affinity Chromatography
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit